It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

According to the NHS, a hacking cough is the primary symptom of the illness. One clear distinction is that a ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

If you're struggling with chronic low back pain, then this is for you. Brad: So we're going to show you three different ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...